SIRT5 and breast carcinoma: In breast cancer, stabilization of mitochondrial glutaminase (GLS) by SIRT5-mediated desuccinylation leads to enhanced proliferation and survival, serving substrates for numerous metabolic pathways, correlating to poorer breast cancer prognosis when found overexpressed [59].